- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 307/06 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 307/06
Total number of patents in this class: 80
10-year publication summary
|
2
|
5
|
6
|
5
|
9
|
6
|
8
|
6
|
3
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | 270 |
3 |
| BASF SE | 19740 |
2 |
| Arbutus Biopharma Corporation | 183 |
2 |
| National University Corporation Hokkaido University | 1323 |
2 |
| Oy Granula AB Ltd | 29 |
2 |
| Teva Pharmaceuticals International GmbH | 355 |
2 |
| Thomas Swan & Co. Ltd. | 21 |
2 |
| The University of North Carolina at Chapel Hill | 1928 |
2 |
| Certa Therapeutics Pty. Ltd. | 11 |
2 |
| F. Hoffmann-La Roche AG | 7958 |
1 |
| Shell Internationale Research Maatschappij B.V. | 3792 |
1 |
| The Regents of the University of California | 18943 |
1 |
| Merck Sharp & Dohme Corp. | 2247 |
1 |
| AstraZeneca AB | 3042 |
1 |
| ExxonMobil Research And Engineering Company | 2830 |
1 |
| Merck Patent GmbH | 5909 |
1 |
| Syngenta Participations AG | 4970 |
1 |
| Evonik Degussa GmbH | 1574 |
1 |
| BASF AG | 1258 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 723 |
1 |
| Other owners | 50 |